Onorach Clinical, a clinical research organization (CRO) providing products and services for medical device and drug clinical trials for Phase I to IV clinical trials, has just acquired Latvia-based RECRI as part of its internationalization strategy. RECRI, which is based in Riga, is a site management organization (SMO) that provides clinical trial related services to CROs, pharmaceutical, biotechnology and medical device companies and clinical sites. The acquisition of RECRI will see an expa...